InvestorsHub Logo
Followers 25
Posts 4731
Boards Moderated 0
Alias Born 07/18/2006

Re: None

Wednesday, 04/24/2024 4:28:00 PM

Wednesday, April 24, 2024 4:28:00 PM

Post# of 458511
I’ll restate what I’ve said previously. If a big pharma thought Anavex had the best approach or even a viable approach to CNS diseases, they’d have acquired the company already even if they had to pay a big premium. At the current market cap, this is lunch money for pharma.

I believe shareholders would be thrilled to get $10-$12 right now if it was offered.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News